Celastrol-Ligustrazine compound proven to be a novel drug candidate for idiopathic pulmonary fibrosis by intervening in the TGF-β1 mediated pathways-an experimental in vitro and vivo study - Lu Gao; Ying Bai; Chao Liang; Tao Han; Yafeng Liu; Jiawei Zhou; Jianqiang Guo; Jing Wu; Dong Hu (Molecular Diversity, 2025)